PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.95%
Revenue growth under 50% of MRVL's 4.78%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
1.45%
Gross profit growth under 50% of MRVL's 3.56%. Michael Burry would be concerned about a severe competitive disadvantage.
-0.33%
Negative EBIT growth while MRVL is at 4.64%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-0.33%
Negative operating income growth while MRVL is at 4.64%. Joel Greenblatt would press for urgent turnaround measures.
0.90%
Net income growth under 50% of MRVL's 6.81%. Michael Burry would suspect the firm is falling well behind a key competitor.
1.79%
EPS growth under 50% of MRVL's 6.25%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
1.82%
Diluted EPS growth under 50% of MRVL's 10.00%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.94%
Share reduction while MRVL is at 1.11%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.17%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-1.03%
Dividend reduction while MRVL stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
22.29%
OCF growth at 75-90% of MRVL's 24.90%. Bill Ackman would demand better working capital management or cost discipline.
10.25%
FCF growth under 50% of MRVL's 23.14%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
163.00%
10Y revenue/share CAGR under 50% of MRVL's 844.36%. Michael Burry would suspect a lasting competitive disadvantage.
25.66%
5Y revenue/share CAGR under 50% of MRVL's 99.06%. Michael Burry would suspect a significant competitive gap or product weakness.
17.83%
3Y revenue/share CAGR at 75-90% of MRVL's 23.77%. Bill Ackman would expect new product strategies to close the gap.
66.82%
10Y OCF/share CAGR under 50% of MRVL's 4026.67%. Michael Burry would worry about a persistent underperformance in cash creation.
32.66%
Below 50% of MRVL's 146.83%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
38.83%
3Y OCF/share CAGR under 50% of MRVL's 545.58%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
628.47%
Below 50% of MRVL's 11837.55%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-62.18%
Negative 5Y net income/share CAGR while MRVL is 146.49%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
30.50%
Below 50% of MRVL's 452.95%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
33.35%
Below 50% of MRVL's 1151.86%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
14.54%
Below 50% of MRVL's 60.58%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
24.70%
3Y equity/share CAGR at 50-75% of MRVL's 39.98%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
528.07%
Dividend/share CAGR of 528.07% while MRVL is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
328.75%
Dividend/share CAGR of 328.75% while MRVL is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
29.76%
3Y dividend/share CAGR of 29.76% while MRVL is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
6.63%
AR growth well above MRVL's 9.37%. Michael Burry fears inflated revenue or higher default risk in the near future.
5.01%
Inventory shrinking or stable vs. MRVL's 15.81%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
28.46%
Asset growth above 1.5x MRVL's 7.06%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
4.09%
75-90% of MRVL's 4.86%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
No Data
No Data available this quarter, please select a different quarter.
0.47%
R&D dropping or stable vs. MRVL's 4.15%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
3.79%
SG&A growth well above MRVL's 1.25%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.